Companies
/Healthcare
Veracyte Inc
$45.29
â–² $1.00 (+2.26%) today
Markets open · 11:45am ET
Today · % change
Fundamentals
Market Cap
$3.6B
P/E Ratio
31.4
Profit Margin
20.4%
Revenue (TTM)
$561.9M
EPS (TTM)
$1.41
52-Week Range
$29 – $61
Street Target
$57.82
About Veracyte
Veracyte Inc is a global diagnostics company that specializes in providing genomic tests and classifiers to accurately diagnose various cancers and lung diseases. Its product lineup includes solutions for prostate cancer, breast cancer, lung cancer, and interstitial lung diseases. Notably, Veracyte is working on innovative tools like the Percepta Genomic Atlas and LymphMark to enhance cancer treatment decisions. Founded in 2006 and based in South San Francisco, California, Veracyte has evolved from its original name, Calderome, Inc., to become a leader in the precision medicine field.